Randomized, double-blind, placebo-controlled study of the analgesic effect of intraoperative esmolol for laparoscopic gastroplasty

Vinicius Barros Duarte de Morais, Rioko Kimiko Sakata, Ana Paula Santana Huang, Leonardo Henrique da Cunha Ferraro, Vinicius Barros Duarte de Morais, Rioko Kimiko Sakata, Ana Paula Santana Huang, Leonardo Henrique da Cunha Ferraro

Abstract

Purpose: To evaluate the analgesic effect of esmolol in patients submitted to laparoscopic gastroplasty.

Methods: Forty patients aged between 18 and 50 years with American Society of Anesthesiologists (ASA) physical status scores of II and III who underwent gastric bypass were allocated to two groups. Group 1 patients received a 0.5-mg/kg bolus of esmolol in 30 mL of saline before induction of anesthesia, followed by an infusion at 15 µg/kg/min until the end of surgery. Group 2 patients received 30 mL of saline as a bolus and then an infusion of saline. Anesthesia included fentanyl (3 µg/kg), propofol (2-4 mg/kg), rocuronium (0.6 mg/kg), and 2% sevoflurane, with remifentanil if necessary. The following parameters were evaluated: pain intensity over 24h, remifentanil consumption, the first analgesic request, morphine consumption, and side effects.

Results: Pain intensity was lower in the esmolol group except at T0 (after extubation) and 12h postoperatively. Remifentanil supplementation, recovery time, and postoperative morphine supplementation were lower in the esmolol group. No differences in the time to the first analgesic request or side effects were found between the groups.

Conclusion: Intraoperative esmolol promotes reductions in pain intensity and the need for analgesic supplementation without adverse effects, thus representing an effective drug for multimodal analgesia in gastroplasty.

Conflict of interest statement

Conflict of interest: none

Figures

Figure 1. CONSORT flowchart.
Figure 1. CONSORT flowchart.

References

    1. Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. 10.1213/ane.0b013e318187c83aAnesth Analg. 2008;107(5):1543–1546.
    1. Wheeler M, Oderda GM, Ashburn MA, Lipman A G. Adverse events associated with post-operative opioid analgesia: a systematic review. 10.1054/jpai.2002.123652J Pain. 2002;3(3):159–180.
    1. Chia YY, Chan MH, Ko NH, Liu K. Role of beta-blockade in anesthesia and postoperative pain management after hysterectomy. 10.1093/bja/aeh268Br J Anaesth. 2004;93(6):799–805.
    1. Collard V, Mistraletti G, Taqi A, Asenjo JF, Feldman LS, Fried GM, Carli F. Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy. 10.1213/01.ane.0000282822.07437.02Anesth Analg. 2007;105(5):1255–1262.
    1. Yasui Y, Masaki E, Kato F. Esmolol modulates inhibitory neurotransmission in the substantia gelatinosa of the spinal trigeminal nucleus of the rat. 1510.1186/1471-2253-11-15BMC Anesthesiol. 2011;5(11)
    1. Pertovaara A. The noradrenergic pain regulation system: a potential target for pain therapy. 10.1016/j.ejphar.2013.01.067Eur J Pharmacol. 2013;716(1-3):2–7.
    1. Tanahashi S, Iida H, Dohi S, Oda A, Osawa Y, Yamaguchi S. Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons. 10.1097/EJA.0b013e32831ac268Eur J Anaesthesiol. 2009;26(3):196–200.
    1. Lee MH, Chung MH, Han CS, Lee JH, Choi YR, Choi EM, Lim HK, Cha YD. Comparison of effects of intraoperative esmolol and ketamine infusion on acute postoperative after remifentanil-based anesthesia in patients undergoing laparoscopic cholecystectomy. 10.4097/kjae.2014.66.3.222Korean J Anesthesiol. 2014;66(3):222–229.
    1. López-Álvarez S, Mayo-Moldes M, Zaballos M, Iglesias BG, Blanco-Dávila R. Esmolol versus ketamine-remifentanil combination for early postoperative analgesia after laparoscopic cholecystectomy. Can J Anaesth. 2012;59(5):442–448. doi: 10.1007/s12630-012-9684-x.
    1. Celebi N, Cizmeci EA, Canbay O. Intraoperative esmolol infusion reduces postoperative analgesic consumption and anaesthetic use during septorhinoplasty: a randomized trial. Rev Bras Anestesiol. 2014;64(5):343–349. doi: 10.1016/j.bjan.2013.10.013.
    1. Coloma M, Chiu JW, White PF, Armbruster SC. The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery. 10.1097/00000539-200102000-00014Anesth Analg. 2001;92(2):352–357.
    1. Cooke FE, Samuels JD, Pomp A, Gadalla F, Wu X, Afaneh C, Gregory F, Goldstein DA. Randomized, double-blind, placebo-controlled trial of intravenous acetaminophen on hospital length of stay in obese individuals undergoing sleeve gastrectomy. 10.1007/s11695-018-3316-7Obes Surg. 2018;28:2998–3006.
    1. Watts R, Thiruvenkatarajan V, Calvert M, Newcombe G, van Wijk RM. The effect of peri-operative esmolol on early postoperative pain: A systematic review and meta-analysis. 10.4103/0970-9185.202182J Anaesthesiol Clin Pharmacol. 2017;33:28–39.
    1. Ozturk T, Kaya H, Aran G, Aksum M, Savacu S. Postoperative beneficial effects of esmolol in treated hypertensive patients undergoing laparoscopic cholecystectomy. 10.1093/bja/aem333Br J Anaesth. 2008;100(2):211–214.
    1. Hwang WJ, Moon YE, Cho SJ, Lee J. The effect of a continuous infusion of low-dose esmolol on the requirement for remifentanil during laparoscopic gynecologic surgery. 10.1016/j.jclinane.2012.06.005J Clin Anesth. 2013;25(1):36–41.
    1. Santonocito C, Noto A, Crimi C, Sanfilippo F. Remifentanil-induced postoperative hyper-algesia: current perspectives on mechanisms and therapeutic strategies. 10.2147/LRA.S143618Local Reg Anesth. 2018;11:15–23.
    1. Leal PC, Salomão R, Brunialti MK, Sakata RK. Evaluation of the effect of ketamine on remifentanil-induced hyperalgesia: a double-blind, randomized study. 10.1016/j.jclinane.2015.02.002J Clin Anesth. 2015;27(4):331–337.
    1. Yu SK, Tait G, Karkouti K, Wijeysundera D, McCluskey S, Beattie WS. The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials. 10.1213/ANE.0b013e3182025af7Anesth Analg. 2011;112(2):267–281.
    1. Dereli N, Tutal ZB, Babayigit M, Kurtay A, Sahap M, Horasanli E. Effect of intraoperative esmolol infusion on anesthetic, analgesic requirements and postoperative nausea-vomitting in a group of laparoscopic cholecystectomy patients. Rev Bras Anestesiol. 2015;65(2):141–146.
    1. Talwar V, Ganeriwal V, Aggarwal S, Gupta A. Efficacy of combination of esmolol and dil-tiazem for attenuating hemodynamic response to laryngoscopy and intubation: a prospective randomized study. 10.4103/aer.AER_76_18Anesth Essays Res. 2018;12(3):674–679.
    1. Zhang XK, Hu Q, Chen QH, Wang WX. The effect of continuous perfusion of esmolol on cardiovascular risk in elderly patients undergoing noncardiac surgery. Pharmazie. 2017;72(8):487–489. doi: 10.1691/ph.2017.6992.
    1. Thiruvenkatarajan V, Watts R, Calvert M, Newcombe G, Van Wijk RM. The effect of esmolol compared to opioids on postoperative nausea and vomiting, postanesthesia care unit discharge time, and analgesia in noncardiac surgery: a meta-analysis. J Anaesth Clin Pharmacol. 2017;33(2):172–180. doi: 10.4103/0970-9185.209747.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner